<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

MiXeno™ - a Rapid and Simple Strategy for Model Humanization

Despite the unprecedented success of immune checkpoint antibodies for a variety of cancer types, a lack of immunocompetent preclinical mouse models remains a major challenge for the development of novel immunotherapeutics.